Registro:

Referencias:

• Missale, C., Nash, S.R., Robinson, S.W., Jaber, M., Caron, M.G., Dopamine receptors: From structure to function (1998) Physiol Rev, 78, pp. 189-225
• Muller, E.E., Locatelli, V., Cocchi, D., Neuroendocrine control of growth hormone secretion (1999) Physiol Rev, 79, pp. 511-607
• Kitajima, N., Chihara, K., Hiromi, H., Okimura, Y., Fujii, Y., Sato, M., Shakutsui, S., Fufita, T., Effects of dopamine on immunoreactive growth hormone-releasing factor and somatostatin secretion from rat hypothalamic slices perfused in vitro (1989) Endocrinology, 124, pp. 69-76
• Massara, F., Camanni, F., Effect of various adrenergic receptor stimulating and blocking agents on human growth hormone secretion (1972) J Endocrinol, 54, pp. 195-206
• Masala, A., Delitala, G., Alagna, S., Devilla, L., Effect of pimozide on levodopa-induced growth hormone release in man (1977) Clin Endocrinol (Oxf), 7, pp. 253-256
• Cammani, F., Massara, F., Phentolamine inhibition of human growth hormone secretion induced by L-DOPA (1972) Horm Metab Res, 4, p. 128
• Bluet-Pajot, M.T., Mounier, F., Durand, D., Kordon, C., Involvement of dopamine D1 receptors in the control of growth hormone secretion in the rat (1990) J Endocrinol, 127, pp. 191-196
• Ferone, D., De Herder, W.W., Pivonello, R., Kros, J.M., Van Koetsveld, P.M., De Jong, T., Minuto, F., Hofland, L.J., Correlation of in vitro and in vivo somatotropic adenoma responsiveness to somatostatin analogs and dopamine agonists with immunohistochemical evaluation of soma-tostatin and dopamine receptors and electron microscopy (2008) J Clin Endocrinol Metab, 93, pp. 1412-1417
• Saveanu, A., Jaquet, P., Brue, T., Barlier, A., Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas (2008) Mol Cell Endo-crinol, 286, pp. 206-213
• Saveanu, A., Lavaque, E., Gunz, G., Barlier, A., Kim, S., Taylor, J.E., Culler, M.D., Jaquet, P., Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cells (2002) J Clin Endocrinol Metab, 87, pp. 5545-5552
• Rocheville, M., Lange, D.C., Kumar, U., Patel, S.C., Patel, R.C., Patel, Y.C., Receptors for dopamine and soma-tostatin: Formation of hetero-oligomers with enhanced functional activity (2000) Science, 288, pp. 154-157
• Ferone, D., Pivonello, R., Lastoria, S., Faggiano, A., Del Basso De Caro, M.L., Cappabianca, P., Lombardi, G., Colao, A., In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolacti-naemic acromegalics: Correlation with somatostatin and dopamine D2 receptor scintigraphy (2001) Clin Endocrinol (Oxf), 54, pp. 469-477
• Huseman, C.A., Hassing, J.M., Evidence for dopaminergic stimulation of growth velocity in some hypop-ituitary children (1984) J Clin Endocrinol Metab, 58, pp. 419-425
• Miyake, H., Nagashima, K., Onigata, K., Nagashima, T., Takano, Y., Morikawa, A., Allelic variations of the D2 dopamine receptor gene in children with idiopathic short stature (1999) J Hum Genet, 44, pp. 26-29
• Kelly, M.A., Rubinstein, M., Asa, S.L., Zhang, G., Saez, C., Bunzow, J.R., Allen, R.G., Low, M.J., Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice (1997) Neuron, 19, pp. 103-113
• Cristina, C., García-Tornadú, I., Diaz-Torga, G., Rubinstein, M., Low, M.J., Becu-Villalobos, D., The dopaminergic D2 receptor knockout mouse: An animal model of prolactinoma (2006) Front Horm Res, 35, pp. 50-63
• Asa, S.L., Kelly, M.A., Grandy, D.K., Low, M.J., Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice (1999) Endocrinology, 140, pp. 5348-5355
• Diaz-Torga, G., Feierstein, C., Libertun, C., Gelman, D., Kelly, M.A., Low, M.J., Rubinstein, M., Becu-Villalobos, D., Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice (2002) Endocrinology, 143, pp. 1270-1279
• Simonian, S.X., Murray, H.E., Gillies, G.E., Herbison, A.E., Estrogen-dependent ontogeny of sex differences in somatostatin neurons of the hypothalamic periventricular nucleus (1998) Endocrinology, 139, pp. 1420-1428
• Cuttler, L., Welsh, J.B., Szabo, M., The effect of age on somatostatin suppression of basal, growth hormone (GH)-releasing factor-stimulated and dibutyril adenosine 3'-5'-monophosphate- stimulated GH release from rat pituitary cells in monolayer culture (1986) Endocrinology, 119, pp. 152-158
• Garcia-Tornadu, I., Rubinstein, M., Gaylinn, B.D., Hill, D., Arany, E., Low, M.J., Diaz-Torga, G., Becu-Villalobos, D., GH in the dwarf dopaminergic D2 receptor knockout mouse: Somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin (2006) J Endocrinol, 190, pp. 611-619
• Waxman, D.J., O'Connor, C., Growth hormone regulation of sex-dependent liver gene expression (2006) Mol Endocrinol, 20, pp. 2613-2629
• Norstedt, G., Palmiter, R., Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver (1984) Cell, 36, pp. 805-812
• Logan, D.W., Marton, T.F., Stowers, L., Species specificity in major urinary proteins by parallel evolution (2008) PLoS ONE, 3, pp. e3280
• Al Shawi, R., Wallace, H., Harrison, S., Jones, C., Johnson, D., Bishop, J.O., Sexual dimorphism and growth hormone regulation of a hybrid gene in transgenic mice (1992) Mol Endocrinol, 6, pp. 181-190
• McGuinness, L., Magoulas, C., Sesay, A.K., Mathers, K., Carmignac, D., Manneville, J.B., Christian, H., Robinson, I.C., Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice (2003) Endocrinology, 144, pp. 720-731
• Lin, S.C., Lin, C.R., Gukovsky, I., Lusis, A.J., Sawchenko, P.E., Rosenfeld, M.G., Molecular basis of the little mouse phenotype and implications for cell type-specific growth (1993) Nature, 364, pp. 208-213
• Cella, S.G., Locatelli, V., Broccia, M.L., Menegola, E., Giavini, E., De Gennaro Colonna, V., Torsello, A., Muller, E.E., Long-term changes of somatotrophic function induced by deprivation of growth hormone-releasing hormone during the fetal life of the rat (1994) J Endocrinol, 140, pp. 111-117
• Robinson, G.M., Spencer, G.S., Berry, C.J., Dobbie, P.M., Hodgkinson, S.C., Bass, J.J., Evidence of a role for growth hormone, but not for insulin-like growth factors i and II in the growth of the neonatal rat (1993) Biol Neonate, 64, pp. 158-165
• Maheshwari, H.G., Silverman, B.L., Dupuis, J., Baumann, G., Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: Dwarfism of Sindh (1998) J Clin Endocrinol Metab, 83, pp. 4065-4074
• Wehrenberg, W.B., Brazeau, P., Luben, R., Ling, N., Guillemin, R., A noninvasive functional lesion of the hypothalamo-pituitary axis for the study of growth hormone-releasing factor (1983) Neuroendocrinology, 36, pp. 489-491
• Bloch, B., Ling, N., Benoit, R., Wehrenberg, W.B., Guillemin, R., Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence (1984) Nature, 307, pp. 272-273
• Flavell, D.M., Wells, T., Wells, S.E., Carmignac, D.F., Thomas, G.B., Robinson, I.C., Dominant dwarfism in transgenic rats by targeting human growth hormone (GH) expression to hypothalamic GH-releasing factor neurons (1996) EMBO J, 15, pp. 3871-3879
• Alba, M., Salvatori, R., A mouse with targeted ablation of the growth hormone-releasing hormone gene: A new model of isolated growth hormone deficiency (2004) Endocrinology, 145, pp. 4134-4143
• Le Tissier, P.R., Carmignac, D.F., Lilley, S., Sesay, A.K., Phelps, C.J., Houston, P., Mathers, K., Robinson, I.C., Hypothalamic growth hormone-releasing hormone (GHRH) deficiency: Targeted ablation of GHRH neurons in mice using a viral ion channel transgene (2005) Mol Endocrinol, 19, pp. 1251-1262
• Mathews, L.S., Hammer, R.E., Brinster, R.L., Palmiter, R.D., Expression of insulin-like growth factor i in transgenic mice with elevated levels of growth hormone is correlated with growth (1988) Endocrinology, 123, pp. 433-437
• Reid, J.D., Congenital absence of the pituitary gland (1960) J Pediatr, 56, pp. 658-664
• Fodor, M., Kordon, C., Epelbaum, J., Anatomy of the hypophysiotropic somatostatinergic and growth hormone-releasing hormone system minireview (2006) Neurochem Res, 31, pp. 137-143
• Bouyer, K., Loudes, C., Robinson, I.C., Epelbaum, J., Faivre-Bauman, A., Sexually dimorphic distribution of sst2A somatostatin receptors on growth hormone-releasing hormone neurons in mice (2006) Endocrinology, 147, pp. 2670-2674
• Slama, A., Bluet-Pajot, M.T., Mounier, F., Videau, C., Kordon, C., Epelbaum, J., Effects of neonatal administration of octreotide, a long-lasting somatostatin analogue, on growth hormone regulation in the adult rat (1996) Neuroendocrinology, 63, pp. 173-180
• Ezzat, S., Walpola, I.A., Ramyar, L., Smyth, H.S., Asa, S.L., Membrane-anchored expression of transforming growth factor-α in human pituitary adenoma cells (1995) J Clin Endocrinol Metab, 80, pp. 534-539
• Mann, K., Rossbach, W., Muller, M.J., Muller-Siecheneder, F., Pott, T., Linde, I., Dittmann, R.W., Hiemke, C., Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine (2006) Psycho-neuroendocrinology, 31, pp. 256-264

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------